Susquehanna International Group
CTSO icon

Susquehanna International Group’s Cytosorbents Corp CTSO Stock Holding History

Susquehanna International Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-535
Closed -$15K – 12600
2022
Q3 		$15K Sell
535
-250
-32% -$9.77K ﹤0.01% 12695
2022
Q2 		$34K Buy
+785
New +$36K ﹤0.01% 12161
2022
Q1 		– Sell
-880
Closed -$74K – 13116
2021
Q4 		$74K Sell
880
-1,820
-67% -$204K ﹤0.01% 12330
2021
Q3 		$438K Sell
2,700
-2,845
-51% -$462K ﹤0.01% 9724
2021
Q2 		$837K Sell
5,545
-2,145
-28% -$361K ﹤0.01% 8251
2021
Q1 		$1.33M Buy
7,690
+5,220
+211% +$995K ﹤0.01% 6961
2020
Q4 		$394K Buy
2,470
+230
+10% +$38.5K ﹤0.01% 8758
2020
Q3 		$357K Sell
2,240
-40
-2% -$7.22K ﹤0.01% 8358
2020
Q2 		$451K Sell
2,280
-1,195
-34% -$219K ﹤0.01% 7572
2020
Q1 		$537K Buy
3,475
+2,765
+389% +$279K ﹤0.01% 6781
2019
Q4 		$55K Buy
+710
New +$61.9K ﹤0.01% 9321
2019
Q2 		– Sell
-760
Closed -$115K – 10286
2019
Q1 		$115K Buy
+760
New +$118K ﹤0.01% 8187
2018
Q3 		– Sell
-610
Closed -$139K – 9342
2018
Q2 		$139K Sell
610
-85
-12% -$16.1K ﹤0.01% 8891
2018
Q1 		$98K Sell
695
-730
-51% -$110K ﹤0.01% 8712
2017
Q4 		$185K Sell
1,425
-1,360
-49% -$173K ﹤0.01% 8337
2017
Q3 		$345K Sell
2,785
-720
-21% -$73.4K ﹤0.01% 7155
2017
Q2 		$301K Buy
3,505
+1,560
+80% +$137K ﹤0.01% 7590
2017
Q1 		$175K Buy
1,945
+1,440
+285% +$161K ﹤0.01% 8108
2016
Q4 		$55K Sell
505
-200
-28% -$21.9K ﹤0.01% 9263
2016
Q3 		$90K Sell
705
-510
-42% -$53K ﹤0.01% 7975
2016
Q2 		$111K Buy
1,215
+255
+27% +$22.2K ﹤0.01% 7970
2016
Q1 		$75K Sell
960
-485
-34% -$42.1K ﹤0.01% 8540
2015
Q4 		$161K Sell
1,445
-1,190
-45% -$162K ﹤0.01% 8598
2015
Q3 		$333K Sell
2,635
-1,040
-28% -$139K ﹤0.01% 7861
2015
Q2 		$454K Buy
+3,675
New +$500K ﹤0.01% 7809

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Susquehanna International Group's CTSO Position: Q2 2026 in Review

Susquehanna International Group sold out of Cytosorbents Corp (CTSO) in Q2 2026, closing a stake of 1,497 shares — an estimated $17K sold.

Susquehanna International Group first reported a position in CTSO in Q1 2015 and held it in 36 quarters. The position peaked at $1.11M in Q3 2017. 47 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Susquehanna International Group reported no remaining Cytosorbents Corp position as of Q2 2026 after selling out during the quarter.
  • Susquehanna International Group sold 1,497 Cytosorbents Corp shares in Q2 2026, an estimated $17K.
  • Susquehanna International Group first reported a position in Cytosorbents Corp in Q1 2015 and held it in 36 quarters.
  • Susquehanna International Group's Cytosorbents Corp position peaked at $1.11M in Q3 2017.
  • 47 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.